KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Long-Term Deferred Tax: 2010-2020

Historic Long-Term Deferred Tax for Emergent BioSolutions (EBS) over the last 9 years, with Mar 2020 value amounting to $17.6 million.

  • Emergent BioSolutions' Long-Term Deferred Tax was N/A to $17.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $13.4 million for FY2019, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Emergent BioSolutions reported Long-Term Deferred Tax of $17.6 million as of Q1 2020, which was up 31.34% from $13.4 million recorded in Q4 2019.
  • In the past 5 years, Emergent BioSolutions' Long-Term Deferred Tax registered a high of $18.2 million during Q2 2016, and its lowest value of $2.8 million during Q4 2017.
  • Its 3-year average for Long-Term Deferred Tax is $13.7 million, with a median of $13.0 million in 2018.
  • Per our database at Business Quant, Emergent BioSolutions' Long-Term Deferred Tax slumped by 72.39% in 2017 and then surged by 378.57% in 2018.
  • Over the past 5 years, Emergent BioSolutions' Long-Term Deferred Tax (Quarterly) stood at $6.1 million in 2016, then tumbled by 54.07% to $2.8 million in 2017, then soared by 378.57% to $13.4 million in 2018, then remained steady at $13.4 million in 2019, then reached $17.6 million in 2020.
  • Its Long-Term Deferred Tax stands at $17.6 million for Q1 2020, versus $13.4 million for Q4 2019 and $13.4 million for Q4 2018.